163 related articles for article (PubMed ID: 17891344)
1. Through the looking glass: the protein science of biosimilars.
Goldsmith D; Kuhlmann M; Covic A
Clin Exp Nephrol; 2007 Sep; 11(3):191-195. PubMed ID: 17891344
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietins, biosimilars and immunogenicity.
Schellekens H
J Nephrol; 2008; 21(4):497-502. PubMed ID: 18651538
[TBL] [Abstract][Full Text] [Related]
3. Biosimilars: recent developments.
Covic A; Kuhlmann MK
Int Urol Nephrol; 2007; 39(1):261-6. PubMed ID: 17333516
[TBL] [Abstract][Full Text] [Related]
4. Global vision about the biological medicinal products: biosimilars (April, 2009).
Zuñiga L; Calvo B
Curr Pharm Biotechnol; 2009 Dec; 10(8):772-4. PubMed ID: 19939216
[TBL] [Abstract][Full Text] [Related]
5. [How to optimize biopharmaceutical treatment safety?].
Prugnaud JL
Bull Acad Natl Med; 2011 Mar; 195(3):679-95; discussion 695-8. PubMed ID: 22292313
[TBL] [Abstract][Full Text] [Related]
6. State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists.
Covic A; Abraham I
Int Urol Nephrol; 2015 Sep; 47(9):1529-39. PubMed ID: 26223197
[TBL] [Abstract][Full Text] [Related]
7. Biosimilars: opportunity or cause for concern?
Roger SD; Mikhail A
J Pharm Pharm Sci; 2007; 10(3):405-10. PubMed ID: 17727803
[TBL] [Abstract][Full Text] [Related]
8. Development and regulation of biosimilars: current status and future challenges.
Tsiftsoglou AS; Ruiz S; Schneider CK
BioDrugs; 2013 Jun; 27(3):203-11. PubMed ID: 23553340
[TBL] [Abstract][Full Text] [Related]
9. Is the advent of biosimilars affecting the practice of nephrology and the safety of patients?
Ronco C
Contrib Nephrol; 2008; 161():261-270. PubMed ID: 18451686
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin use in pregnancy: two cases and a review of the literature.
Scott LL; Ramin SM; Richey M; Hanson J; Gilstrap LC
Am J Perinatol; 1995 Jan; 12(1):22-4. PubMed ID: 7710570
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Romero González R; Torquet Escuder P
Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
[No Abstract] [Full Text] [Related]
12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
14. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
Salim KA; Salim S; Mathew T
J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
[TBL] [Abstract][Full Text] [Related]
15. Biosimilars--global issues, national solutions.
Knezevic I; Griffiths E
Biologicals; 2011 Sep; 39(5):252-5. PubMed ID: 21924623
[TBL] [Abstract][Full Text] [Related]
16. Biosimilars and biopharmaceuticals: what the nephrologist needs to know--a position paper by the ERA-EDTA Council.
Shaldon S
Nephrol Dial Transplant; 2009 May; 24(5):1700-1; discussion 1701. PubMed ID: 19329532
[No Abstract] [Full Text] [Related]
17. [Treatment of renal anemia using synthetic human erythropoietin].
Blumberg A; Zehnder C
Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
[No Abstract] [Full Text] [Related]
18. Progress in biopharmaceutical development.
Kesik-Brodacka M
Biotechnol Appl Biochem; 2018 May; 65(3):306-322. PubMed ID: 28972297
[TBL] [Abstract][Full Text] [Related]
19. Novel erythropoiesis-stimulating agents: a new era in anemia management.
Macdougall IC
Clin J Am Soc Nephrol; 2008 Jan; 3(1):200-7. PubMed ID: 18077782
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
